**Core tip:** Gout is a common inflammatory arthritis that rarely affects the spine. In such cases, patients may experience back pain, myelopathic symptoms and radiculopathy. Clinical findings are non-specific. Therefore, it is necessary to have an awareness of the diagnosis, especially in patients with a clinical history of gout and/or elevated inflammatory markers and hyperuricemia. While magnetic resonance imaging is the major non-invasive diagnostic method, all suspicious findings on imaging require surgical sampling for pathological confirmation. While typical uric acid lowering medications are first-line therapy, cord compression or continued symptoms may necessitate operative intervention if medications fail.

INTRODUCTION
============

Gout is a common inflammatory arthritis with an increase in prevalence over the last 20 years. It currently affects over 8 million Americans. The clinical presentation of gout depends on the site of monosodium urate (MSU) crystals precipitation and the subsequent inflammatory response that ensues in the synovial joints and soft tissues. Gout usually manifests as a monoarticular arthritis in the lower extremities. If untreated, nodular masses of MSU crystals called tophi may eventually deposit in extraarticular locations, such as, the axial skeleton. Although traditionally thought of as a rare complication, recent study suggests that axial gout may be more prevalent than suspected\[[@B1]\]. Gout affecting the spinal column will typically present with neurological compromise, localized pain, and lytic vertebral lesions\[[@B2],[@B3]\]. Spinal gout can affect the facet joint, laminae, ligamentum flavum, as well as the epidural space\[[@B4]\].

From 2000 to 2014, approximately 68 case reports have been published on spinal gout. The current manuscript summarizes the most common presenting features, imaging findings, and treatment choices based on the 68 published cases. A case is also presented to provide illustration on the topic.

MATERIALS AND METHODS
=====================

Literature review
-----------------

A PubMed literature search using the key words spinal gout, from January 2000 to December 2014, limited to human studies and restricted to English language literature resulted in 221 publications. Abstracts and articles were then reviewed for content. Articles kept for review included patients who underwent treatment for spinal gout. Furthermore, data required for inclusion in the study included: Patient demographics, clinical presentation, laboratory findings, imaging studies, and treatment methods were collected (Table [1](#T1){ref-type="table"}). Articles excluded from the study were those that did not have patients diagnosed with spinal gout and those that did not include patient demographics, clinical presentation, laboratory findings, imaging studies, and treatment methods. After review, a total of 54 peer reviewed articles met the above criteria and were included for data collection.

###### 

List of patient cases of spinal gout in the literature since 2000

  **No**.   **Year**   **Ref**.                        **Age/sex**   **Site**                       **Sx/Signs**                                                         **Duration**                     **Hx Gout**    **Tophi**   **Relevant Hx**                                                             **Hi Urate**   **MRI T1**   **T2**   **Gad**   **Tx**
  --------- ---------- ------------------------------- ------------- ------------------------------ -------------------------------------------------------------------- -------------------------------- -------------- ----------- --------------------------------------------------------------------------- -------------- ------------ -------- --------- ----------------------------------------------------------------------------------------------------------------------------------------------------
  1         2000       Kao et al\[[@B5]\]              82 M          T10-T11                        LE weakness                                                          1 mo                             Y              NA          NA                                                                          Y              Iso          Hypo     NA        T9-T11 lamina
  2         2000       Mekelburg et al\[[@B6]\]        60 M          L2-3                           Back pain                                                            5 mo                             Y              NA          NA                                                                          Y              NA           NA       NA        Cervical lamina
  3         2000       Paquette et al\[[@B7]\]         56 M          L3                             Back pain, radicular pain                                            6 yr                             N              NA          Arthritis                                                                   NA             NA           Hypo     NA        Surgery
  4         2000       Thornton et al\[[@B8]\]         27 M          L3-L4                          Back pain                                                            1 d                              Y              NA          RT                                                                          Y              Hypo         NA       Y         Medical NOS
  5         2001       Barrett et al\[[@B9]\]          70 M          L5-S1                          Back pain, radicular pain, fever                                     2 d                              Y              NA          RI                                                                          N              NA           Hyper    Y         Lamina
  6         2001       St George et al\[[@B10]\]       60 M          T1-T2                          LE weakness, BBD                                                     6 wk                             Y              N           NA                                                                          NA             NA           Hypo     NA        T1-T2 lamina
  7         2001       Wang et al\[[@B11]\]            28 M          T9-T10                         LE weakness                                                          1 d                              Y              N           NA                                                                          NA             NA           NA       NA        T9-T10 lamina
  8         2002       Hsu et al\[[@B12]\]             72 M          L4-S1                          Back pain, radicular pain                                            18 mo                            Y              NA          NA                                                                          Y              Hypo         Hyper    Y         Lamina
  9         2002       Hsu et al\[[@B12]\]             77 M          L3-L5                          Back pain, radicular pain                                            12 mo                            N              NA          NA                                                                          Y              Hypo         Hypo     Y         Lumbar lamina
  10        2002       Hsu et al\[[@B12]\]             83 M          T9-T11                         LE weakness                                                          1 mo                             Y              NA          NA                                                                          N              Hypo         Hypo     Y         Lamina
  11        2002       Hsu et al\[[@B12]\]             27 M          L2-S1                          Back pain                                                            6 mo                             Y              NA          NA                                                                          Y              Hypo         Hyper    Y         Medical NOS
  12        2002       Souza et al\[[@B13]\]           49 M          T9-T10                         Back pain, LE weakness                                               6 mo                             Y              NA          NA                                                                          NA             Iso          Hypo     Y         T9-T11 lamina
  13        2002       Yen et al\[[@B14]\]             68 M          C4-C5                          Quadriparesis                                                        2 wk                             Y              NA          RI                                                                          Y              Hypo         Hypo     NA        Surgery
  14        2003       Diaz et al\[[@B15]\]            74 M          C4-C5                          Quadriparesis                                                        1 wk                             Y              Y           NA                                                                          Y              NA           NA       NA        C4-C5 lamina
  15        2004       Draganescu et al\[[@B16]\]      48 F          L4                             Radicular pain                                                       1 d                              Y              Y           Diuretic                                                                    Y              NA           Hetero   Y         L4-L5 lamina
  16        2004       El Sandid et al\[[@B17]\]       32 M          T7-T9                          Back pain, fever                                                     Acute                            Y              NA          NA                                                                          Y              NA           NA       NA        Lamina
  17        2004       Nakajima et al\[[@B18]\]        39 M          L4-5                           Low back pain                                                        NA                               Y              Y           Arthritis                                                                   Y              NA           NA       Y         Medical
  18        2005       Beier et al\[[@B19]\]           29 M          L4-L5                          Back pain, L5 radiculopathy                                          Acute                            N              N           NA                                                                          Y              NA           NA       NA        L4-L5 lamina
  19        2005       Celik et al\[[@B20]\]           48 M          C1-C2                          Neck pain, radiculopathy, paresthesias                               2 mo                             N              Y           Alcohol                                                                     Y              Hypo         Hyper    Y         Medical NOS
  20        2005       Chang\[[@B21]\]                 60 M          L3-L4                          B/L L4 radiculopathy                                                 NA                               Y              NA          NA                                                                          Y              Hypo         Hypo     Y         Surgery
  21        2005       Chang\[[@B21]\]                 72 M          L4-S1                          Back pain, claudication                                              2 wk                             Y              NA          NA                                                                          Y              Hypo         Hypo     Y         Surgery
  22        2005       Chang\[[@B21]\]                 66 F          L4-L5                          Back pain, claudication                                              1 mo                             Y              NA          NA                                                                          Y              Hypo         Hypo     Y         Surgery
  23        2005       Chang\[[@B21]\]                 63 M          L3-S1                          Back pain, claudication, fever                                       2 wk                             NA             NA          NA                                                                          N              Hypo         Hypo     Y         Surgery
  24        2005       Kelly et al\[[@B22]\]           56 F          L4                             Back pain, LE weakness                                               1 mo                             Y              NA          RA, DM, RI                                                                  NA             Iso          Hypo     Y         L4-L5 lamina
  25        2005       Mahmud et al\[[@B23]\]          47 M          L4-L5                          Radiculopathy                                                        3 mo                             Y              NA          NA                                                                          Y              NA           NA       NA        L4-L5 lamina/facet
  26        2005       Mahmud et al\[[@B23]\]          71 F          L4-L5                          Back pain, radiculopathy                                             4 mo                             N              NA          NA                                                                          N              NA           Hetero   NA        L4-L5 lamina/fusion
  27        2005       Mahmud et al\[[@B23]\]          58 M          L4-L5                          Back pain, claudication                                              6 mo                             N              NA          NA                                                                          N              NA           Hyper    NA        L5 lamina
  28        2005       Wazir et al\[[@B24]\]           66 F          C1-C2                          Chronic neck pain, A-A subluxation, quadriparesis                    2 mo                             N              N           Arthritis                                                                   Y              NA           NA       NA        Lamina/fusion
  29        2005       Yen et al\[[@B25]\]             65 F          L5-S1                          Back pain, LE weakness                                               10 mo                            N              NA          NA                                                                          NA             Iso          Hetero   Y         L5-S1 lamina
  30        2006       Dharmadhikari et al\[[@B26]\]   66 F          C3-C7                          Cord compression, quadriparesis, falls                               2-3 mo                           N              N           NA                                                                          NA             Hypo         Hypo     N         C3-C6 vertebrectomy
  31        2006       Hou et al\[[@B27]\]             37 M          L5-S1                          Back pain, fever                                                     5 d                              Y              N           RT                                                                          Y              Iso          Iso      Y         Medical NOS
  32        2006       Oaks et al\[[@B28]\]            32 M          T5-T8                          Back pain, myelopathy                                                NA                               Y              NA          NA                                                                          NA             Hetero       Hetero   Y         Lamina
  33        2006       Pankhania et al\[[@B29]\]       68 M          C4-C5                          Neck pain, quadriparesis, sensory dysfunction                        1 mo                             N              N           NA                                                                          N              Iso          Hetero   Y         Lamina
  34        2006       Popovich et al\[[@B30]\]        36 F          T2-T9                          Paraplegia                                                           2 wk                             Y              NA          NA                                                                          Y              Hypo         Hypo     Y         T5-T7 lamina
  35        2007       Adenwalla et al\[[@B31]\]       77 M          L5-S1                          Severe low back pain, LE weakness                                    1 wk                             N              N           Diurectic                                                                   Y              NA           NA       NA        Prednisone and colchicines
  36        2007       Lam et al\[[@B32]\]             65 M          L3-L4                          LE pain and numbness, BBD                                            Acute                            Y              Y           RI                                                                          Y              NA           NA       NA        L3-L4 lamina
  37        2007       Lam et al\[[@B32]\]             63 M          L4-S1                          Chronic LE pain and paresthesia, claudication                        1 yr                             Y              N           NA                                                                          N              NA           NA       NA        L4-L5 lamina/fusion
  38        2007       Suk et al\[[@B33]\]             55 M          L4-L5                          Back pain, LE weakness and paresthesia, fever                        1 wk                             N              N           Alcohol                                                                     Y              Hypo         Hetero   Y         L4-L5 lamina/fusion
  39        2008       Fontenot et al\[[@B34]\]        85 F          L3-L4                          Low back pain                                                        2 mo                             N              N           Diuretics                                                                   Y              NA           Hyper    NA        Prednisone and colchicines
  40        2009       Chan et al\[[@B35]\]            76 M          T8, T10                        LE weakness                                                                                           Y              Y           NA                                                                          Y              Iso          Hetero   NA        Medical NOS
  41        2009       Nygaard et al\[[@B36]\]         75 M          L4-L5                          Low back pain, fever                                                 5 d                              Y              N           NA                                                                          Y              NA           NA       NA        NA
  42        2009       Tsai et al\[[@B37]\]            64 F          T8-T9                          Fever, low back pain, LE weakness                                    1 d                              N              N           DM, RI                                                                      N              Hypo         Iso      Y         T8-T9 discectomy and partial corpectomy
  43        2010       Coulier et al\[[@B38]\]         62 F          C6-C7                          Neck pain                                                            NA                               N              Y           NA                                                                          Y              NA           NA       NA        NA
  44        2010       Ko et al\[[@B39]\]              63 M          L5-S1                          Low back pain                                                        2 mo                             N              N           NA                                                                          Y              Hypo         Hypo     Y         Lamina
  45        2010       Murphy et al\[[@B40]\]          82 M          NA                             Back pain                                                            3 mo                             N              Y           NA                                                                          NA             NA           NA       NA        NA
  46        2010       Ntsiba et al\[[@B41]\]          43 M          T9-T10                         Spastic paraplegia                                                   6 mo                             Y              Y           Alcohol                                                                     NA             Hypo         Hyper    NA        T10 lamina
  47        2010       Samuels et al\[[@B42]\]         75 M          L5-S1                          Low back pain, radiculopathy, b/l groin pain                         Acute                            Y              N           DM, RI, arthritis                                                           NA             NA           NA       NA        Steroid injection and allopurinol
  48        2011       Ibrahim et al\[[@B43]\]         70 F          T1-T2                          UE and LE weakness                                                   1 yr                             Y              N           RI                                                                          Y              Hypo         Hyper    NA        Lamina/fusion
  49        2011       Levin et al\[[@B44]\]           34 M          T2-T5                          Paraplegia                                                           Acute                            Y              N           RI, DM                                                                      Y              NA           NA       NA        Lamina
  50        2011       Thavarajah et al\[[@B45]\]      57 M          C1-C2                          Neck pain, UE and LE tingling                                        1 yr                             Y              N           NA                                                                          NA             NA           NA       NA        C0-C6 fusion
  51        2011       Tran et al\[[@B46]\]            73 M          C1-C2                          CN IX, X, XII palsies, fever, cough,                                 3 d                              Y              Y           RI                                                                          Y              NA           Hetero   NA        Allopurinol, rasburicase
  52        2012       Federman et al\[[@B2]\]         66 M          C4-C6                          Neck pain                                                            4 mo                             N              N           DM                                                                          Y              Hypo         Hetero   NA        Allopurinol, colchicine, narcotic analgesics
  53        2012       Hasturk et al\[[@B4]\]          77 F          L4-L5                          Low back pain, radiculopathy                                         5 mo                             N              N           NA                                                                          N              Hypo         Hypo     Y         Surgery
  54        2012       Sakamoto et al\[[@B3]\]         69 M          L1-L2                          Back pain, radiculopathy                                             Acute                            N              N           Heart Failure                                                               Y              Hypo         Hypo     Y         Medical NOS
  55        201        Yamamoto et al\[[@B47]\]        58 F          C4-C7                          Malaise, fever, back pain                                            3 yr                             N              Y           Arthritis, RI                                                               Y              NA           NA       NA        Prednisolone, allopurinol, benzbromarone
  56        2012       Lu et al\[[@B48]\]              29 M          L4-S1                          Severe pain, paresthesia, acratia of LLE                             3 yr                             Y              Y           Chronic alcohol abuse, chronic gout                                         Y              Hypo         Hypo     NA        L4-L5/L5-S1 decompression/fusion
  57        2012       Sanmillan et al\[[@B49]\]       71 M          C3-C4                          Progressive Quadriparesis                                            4 mo                             Y              Y           Hypertension, dislipidemia                                                  Y              Hypo         Hyper    NA        C3-C4 microdiscectomy/fusion
  58        2013       Wendling et al\[[@B50]\]        54 M          C5-C6                          Inflammatory neck pain and cervicobrachial neuralgia                 Acute                            Y              N           Hyperch- olesterolemia                                                      Y              Hypo         NA       Y         Colchicine
  59        2013       Wendling et al\[[@B50]\]        52 F          Lumbar posterior facet joint   Low back pain                                                        NA                               N              Y           Polychondritis                                                              N              NA           NA       NA        Surgery
  60        2013       Wendling et al\[[@B50]\]        72 M          C5-C6                          Acute neck pain, knee arthritis                                      Acute                            Y              N           Hypertension                                                                Y              NA           NA       NA        Colchicine
  61        2013       Wendling et al\[[@B50]\]        65 M          L4-L5                          Inflammatory low back pain                                           Acute                            Y              Y           Cardio- myopathy, hypertension                                              Y              NA           NA       NA        Colchicine
  62        2013       Wendling et al\[[@B50]\]        87 M          L3-L5                          Inflammatory low back pain                                           Acute                            N              Y           Hypertension, heart failure, chronic kidney failure                         Y              Hypo         NA       Y         Colchicine
  63        2013       Komarla et al\[[@B51]\]         69 F          L3-S1                          Back pain, fever                                                     Acute                            N              Y           Alchohol abuse, chronic low back pain                                       N              NA           Hyper    NA        Allopurinol, colchicine, glucocorticoids
  64        2013       de Parisot et al\[[@B52]\]      60 M          C1-C2                          Walking disorders, urinary and bowel incontinence                    6 mo                             Y              Y           NA                                                                          Y              Hypo         Hyper    Y         C1-C2 Arthrodesis
  65        2013       Kwan et al\[[@B53]\]            25 M          T9-T10, L3-S1                  Pain, swelling, and decreased ROM in multiple joints                 1 wk                             N              Y           CKD                                                                         Y              Hypo         Hetero   NA        Prednisone, allopurinol
  66        2013       Yoon et al\[[@B54]\]            64 M          T5-T7                          Weakness B/L LE, back pain rad to left anterior chest, paraparesis   Weakness: 1 wk; back pain 1 mo   Y (8 yr ago)   Y           Acute gout arthritis 8 yr prior                                             Y              Hypo         Hetero   Y         T5-T7, laminectomy, facetectomy, pedicle screw fixation w/PL fusion
  67        2013       Jegapragasan et al\[[@B55]\]    24 M          L4-S1                          Progressively worsening LBP w/rad, weakness of RLE, fever            3 yr LBP rad lat thight          Y (4 yr Hx)                4 yr Tophaceous gout, CKD, 3 yr LBP, rad pain down later thigh (Rt \> Lf)   Y              Iso          Hetero   NA        Decompressive laminectomy L4-S1, resection of intraspinal canal and perineural lesion; post-op: colchicine, allopurinol, brief burst of prednisone
  68        2014       Cardoso et al\[[@B56]\]         69 W          L4-5, SI joints                LBP rad to buttocks and hips, low fever                              NA                               N              Y           Constrictive pericarditis, chronic renal insufficiency, HTN, DM             Y              Hypo         Iso      Y         Colchicine, allopurinol

M: Male; F: Female; Sx: Symptoms; Hx: History; RT: Renal transplant; Hi: High; R: Right; LE: Lower extremity; RI: Renal insufficiency; BBD: Bowel/bladder dysfunction; Y and N: Yes and no; Hypo: Hypointense; Iso: Isointense; Hyper: Hyperintense; Hetero: Heterointense; UE: Upper extremity; Lamina: Laminectomy; Tx: Treatment; Gad: Gadolinium.

RESULTS
=======

The 54 articles accounted for 68 cases of spinal gout with 51 (75%) males and 17 (25%) females and an average age of 59.2 years, 41(60.3%) had prior history of peripheral gout (Table [1](#T1){ref-type="table"}).

Clinical presentations
----------------------

Of the 68 spinal gout patients reviewed, 47 (69.1%) presented with localized back/neck pain, 38 (55.9%) with some form of spinal cord compression, defined as weakness, numbness, loss of bladder or bowel control, and decreased sensation below the compression level, 17 (25%) with spinal nerve root compression or radiculopathy, defined as motor dysfunction or dysesthesia along the course of a specific nerve caused by compression of its root, 13 (19.1%) with fever, 1 (1.5%) with cranial nerve palsy, and 2 (3.0%) with atlanto-axial subluxation (Table [2](#T2){ref-type="table"}). Furthermore, among the sites of involvement in the 68 spinal gout patients, 38 (55.9%) were located in the lumbar region, 15 (22.1%) in the thoracic region, 15 (22.1%) in the cervical region, and 1 (1.4%) in an unspecified region (Table [3](#T3){ref-type="table"}). One patient demonstrated soft tissue nodularity consistent with gouty tophi on biopsy in both the thoracic and lumbar spinal segments.

###### 

Clinical features

  **No. of patients**                         
  ------------------------------------------- ----
  Localized back/neck pain                    47
  Spinal nerve root compression, in general   14
  Radicular pain                              6
  Radiculopathy NOS                           8
  Spinal cord compression, in general         38
  LE weakness                                 19
  Quadriparesis                               6
  Claudication                                5
  Paraplegia                                  4
  BBD                                         3
  Myelopathy NOS                              1
  Cranial nerve palsy                         1
  Atlanto-axial subluxation                   2
  Fever                                       13

NOS: Not otherwise specified; UE: Upper extremity; LE: Lower extremity; BBD: Bowel/bladder dysfunction.

###### 

Anatomic location of spinal gout

  **No. of patients**                     
  --------------------------------------- ----
  Lumbar spine                            38
  Thoracic spine                          15
  Cervical spine                          15
  Not mentioned                           1
  Total[1](#T3FN1){ref-type="table-fn"}   68

Patient No. 65 had gout in two sites, thoracic and lumbar regions.

Laboratory studies
------------------

Laboratory studies of the 68 recorded cases showed 45 (66.2%) with elevated uric acid level at the time of diagnoses, 17 (25%) had elevated erythrocyte sedimentation rates (ESR), 19 (27.9%) had increased C-reactive proteins (CRP) level, 11 (16.2%) had renal insufficiency, 9 (13.2%) had leukocytosis, and 5 (7.4%) had anemia (Table [4](#T4){ref-type="table"}).

###### 

Laboratory studies

  **No. of patients**   
  --------------------- ----
  Elevated uric acid    45
  Elevated ESR          17
  Elevated CRP          19
  Renal insufficiency   11
  Leukocytosis          9
  Anemia                5

ESR: Erythrocyte sedimentation rate; CRP: C-reactive protein.

Imaging studies
---------------

On the T1-weighted magnetic resonance imaging (MRI) images, 28 (41.2%) did not report findings, 31 (45.5%) were hypointense, 8 (11.8%) were isointense, and 1 (1.5%) was heterointense. On T2-weighted images, 24 (35.3%) did not report findings, 18 (26.5%) were hypointense, 12 (17.6%) were heterointense, 11 (16.2%) were hyperintense, and 4 (5.9%) were isointense. A gadolinium (Gd)-enhanced MRI scan was obtained from 32 (47.1%) patients. These findings are referenced in (Table [5](#T5){ref-type="table"}).

###### 

Imaging studies

  **No. of patients**      
  ------------------------ ----
  X-ray                    
  Not performed            37
  Spondylosis/-listhesis   12
  Bony erosion             8
  Unremarkable             6
  Degenerative changes     5
  CT                       
  Not performed            35
  BE and HDA               13
  BE only                  13
  Lytic lesions            5
  Unremarkable             2
  MRI                      
  T1                       
  Not reported             28
  Hypointense              31
  Isointense               8
  Heterointense            1
  T2                       
  Not reported             24
  Hypointense              18
  Heterointense            12
  Hyperintense             11
  Isointense               4
  Gadolinium enhancement   
  No                       36
  Yes                      32

BE: Bony erosion; HAD: High density attenuation; CT: Computed tomography; MRI: Magnetic resonance imaging.

Thirty-seven cases (54.4%) did not report X-ray findings, 12 (17.6%) showed spondylosis or spondylisthesis, 8 (11.8%) showed bony erosion, 6 (8.8%) were unremarkable, and 5 (7.4%) showed degenerative changes. In addition, 35 (51.5%) did not report computed tomography (CT) findings, 13 (19.1%) showed bony erosion and high density attenuation, 13 (19.1%) displayed bony erosion only, 5 (7.4%) demonstrated lytic lesions, and 2 (2.9%) were unremarkable.

Treatments
----------

Forty-five (66.2%) patients had surgical treatment. Thirty-five (51.5%) patients had laminectomies, 8 (11.8%) of whom also had fusions with laminectomies, 7 (10.3%) had surgeries not otherwise specified, 1 (1.5%) had a vertebrectomy, 2 (2.9%) had discectomies with partial corpectomies. Twenty (29.4%) received medical treatment alone and 3 (4.4%) did not report any treatment (Table [6](#T6){ref-type="table"}).

###### 

Treatment

  **No. of patients**                      
  ---------------------------------------- ----
  Laminectomy only                         24
  Nonsurgical treatment                    20
  Surgery not specified                    7
  Laminectomy and fusion                   5
  Not reported                             3
  Fusion only                              2
  Laminectomy and facetectomy              3
  Laminectomy and facetectomy and fusion   1
  Vertebrectomy                            1
  Discectomy and partial corpectomy        2
  Total                                    68

Case illustration
-----------------

A 58-year-old female presented with a chief complaint of low back and radicular pain over left L4, 5 dermatomes that had been progressively worsening over a four-month duration to the point where she was unable to walk. The patient denied any saddle paresthesia or change in bowel and bladder function. She has a history of cardiovascular disease, chronic kidney disease (stage I), type II diabetes mellitus, hypertension, obesity, and obstructive sleep apnea. The patient also described an acute gouty arthropathy that was diagnosed in her right hand about 4 mo prior for which she was taking colchicine. An inflammatory workup was ordered which showed CRP of 3.58 (*n* \< 1.0), ESR 25 (0-20), WBC 6.2 (4.0-10.0), uric acid 11.4 (2.5-6.8); HLA-B27, anti-DNA, Rheumatoid factor, and complement labs were negative.

Plain radiograph of the lumbar spine was unremarkable. Plain radiograph of the right hand showed osseous erosive changes at the 4^th^ finger distal interphalangeal (DIP) joint (Figure [1](#F1){ref-type="fig"}). MRI showed intraspinal extradural lesion causing spinal canal stenosis at L4-S1 (Figure [2](#F2){ref-type="fig"}). A CT showed that the lesion was calcified with erosive changes noted at the left L4-5 facet joint and L 4 lamina (Figure [3](#F3){ref-type="fig"}). The patient was treated with L4-S1 decompression, instrumentation and fusion. The surgical microscope was used during excision of the intraspinal lesion, which appeared chalky white, non-adherent and easily pealed off the thecal sac without sustaining dural tear (Figure [4](#F4){ref-type="fig"}). Postoperatively the patient noted significant improvement in both low back and radicular pain. The patient received allopurinol treatment for gout and remained asymptomatic at the last follow up two years after the index procedure.

![Plain radiograph anteroposterior view right hand showed osseous erosive changes at the 4^th^ finger distal interphalangeal joint (arrow).](WJO-7-766-g001){#F1}

![T2 weighted magnetic resonance imaging scan mid sagittal (A) and axial (B) showed intraspinal extradural hypodense lesion causing spinal canal stenosis at L4-S1.](WJO-7-766-g002){#F2}

![Computed tomography scan mid sagittal (A), left parasagittal (B), and axial (C) views showed the intraspinal lesion was calcified with erosive changes at the left L4-5 facet joint and L4 lamina (arrows).](WJO-7-766-g003){#F3}

![Intraoperative photograph taken by the surgical microscope showed a well-demarked chalky white tophous lesion (arrow).](WJO-7-766-g004){#F4}

DISCUSSION
==========

Gout is a common form of inflammatory arthritis caused by the deposition of MSU crystals in synovial joints that result into erosion and joint damage. Soft tissue masses of MSU crystals known as tophi are usually found in the hand and extensor surface of the forearm\[[@B4],[@B32],[@B57]\]. Tophi are seen in patients with long-standing gout, but can also be one of the first symptoms amongst a cluster of metabolic disorders leading to hyperuricemia, especially among those with long-standing renal impairment\[[@B2],[@B33]\]. Tophi are a common manifestation of gout, but spinal manifestations are considered rare. Recent research by de Mello et al\[[@B1]\], however, suggests that tophi in the axial skeleton may be more prevalent than first suspected.

Although no studies have been able to conclude the exact mechanism for axial involvement in gout, the likely theory is, as gout usually involves joint spaces, facet joint may be the initial deposition location for MSU crystals. Another theory is based on the fact that high uric acid and other inflammatory markers are often elevated in gout. This increase in uric acid in the blood could signal a corresponding increase in cerebrospinal fluid (CSF) leading to the obstruction of the canal or foramen.

Literature review showed that the lumbar spine was the most commonly involved region followed by thoracic and cervical regions. The most common clinical presentation was back pain associated with lumbar radiculopathy, or neurogenic claudication. The most frequent laboratory finding was hyperuricemia defined as uric acid above 7 mg/dL. Renal insufficiency was also found in many patients. Plain radiograph findings are usually non-specific. The most consistent image findings of the intraspinal extradural tophi were hypointense signal on the T1-weighted MRI and heterointense signals on the T2-weighted MRI. Spinal gout is usually diagnosed with cytological or histopathological studies. However, for patients treated with surgery, a pasty chalk-white mass are usually present. Clinical presentations and radiological findings of spinal gout are often non-specific and one has to consider the differential diagnoses of intraspinal extradural mass. The most frequent etiology with similar clinical presentations and imaging findings is herniated disc. Other causes include synovial cyst, tumor, epidural abscess, arteriovenous malformation.

Pharmacotherapy for spinal gout is the same as those used for gout involving typical joints. Acute gouty attack is most often treated with nonsteroidal anti-inflammatory drugs (NSAIDs), such as, naproxen or indomethacin. In patients with chronic kidney disease, duodenal or gastric ulcer, heart disease or hypertension, NSAID allergy, or anticoagulant treatment, colchicine is an alternative treatment. While NSAIDs and colchicine are effective in symptomatic reduction during an acute attack, they do not prevent the development of bony erosions or tophi deposits in tissues. To prevent further gouty attack, maintenance medications are often prescribed with the goal of keeping uric acid level less than 6 mg/dL. Xanthine oxidase inhibitors, such as allopurinol, febuxostat, and oxypurinol, are the first line choices for reduced production of uric acid. Allopurinol can precipitate gouty attack or worsen current attack, thus, it is used for maintenance after acute attack has resolved. Uricosuric agents, such as, probenecid and sulfinpyrazone, are second line prophylactics aimed to increase uric acid excretion since decreased uric acid excretion is responsible for 85% to 90% of primary or secondary hyperuricemia\[[@B58]\].

Surgical interventions may be needed if patient has symptoms of spinal cord or nerve root compression. The mainstay of surgical treatment is decompression and excision of the tophi. The role of fusion at the time of the decompression remains controversial. The need for fusion is influenced by symptomatic preoperative instability as evidenced by dynamic radiographs, erosion of the facet joint seen on CT scan, or intraoperative instability that may be created by iatrogenic resection of spinal structures such as the pars interarticularis or the facet joints.

Although this article provides a broad overview of cases involving spinal gout since January 2000, there are some limitations. The absence of certain information, such as the post-treatment outcomes, limited the depth of our analysis in certain cases. Furthermore, the literature review could not always account for individual variation among the 68 cases reviewed including the particular method of diagnosis, which was not standardized across all patients included in the study. In addition, the individual articles did not provide information regarding prior uric acid lowering treatments, which could possibly inflate the number of spinal gout cases with normal uric acid levels.

The majority of clinical features for spinal gout such as back pain and neurological symptoms are nonspecific. Thus, one must rule out other common diagnoses, such as disc herniation, tumor, infection prior to diagnosing a patient with spinal gout. Laboratory study indicative of gout is elevated uric acid levels. In this literature review, the majority of the cases utilized MRI as the radiological study of choice in detecting spinal gout. While MRI was the major non-invasive diagnostic method, all suspicious findings on imaging required surgical sampling for pathological confirmation of negatively birefringent MSU crystals presence.

COMMENTS
========

Background
----------

Gout is a common inflammatory arthritis with an increase in prevalence over the last 20 years. It currently affects over 8 million Americans. The primary aim of this review is to summarize the most common presenting features, imaging findings, and treatment choices based on the 68 published cases.

Research frontiers
------------------

Literature review showed that the lumbar spine was the most commonly involved region followed by thoracic and cervical regions. The most common clinical presentation was back pain associated with lumbar radiculopathy, or neurogenic claudication. The most frequent laboratory finding was hyperuricemia defined as uric acid above 7 mg/dL.

Innovations and breakthroughs
-----------------------------

Traditionally gout thought of as a rare problem characterized by a sudden, severe attacks of pain, redness and tenderness in joints, often the joint at the base of the big toe. Recent studies suggest that axial gout may be more prevalent than suspected. Spinal gout can affect the facet joint, laminae, ligamentum flavum, as well as the epidural spaces.

Applications
------------

The majority of clinical features for spinal gout such as back pain and neurological symptoms are nonspecific. Suspicious findings on MRI imaging required surgical sampling for pathological confirmation of negatively birefringent monosodium urate crystals presence.

Peer-review
-----------

It is a good review concerning the spinal gout consisting of the symptom and signs, treatment option and lab data analysis.
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